News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

AMBLor is a groundbreaking histopathological biomarker test for the personal identification of early-stage melanomas at low risk of progression, post staging diagnosis.

Cancer Research Horizons, the innovation arm of Cancer Research UK, has appointed Carlos Garcia-Echeverria, Katharina Kreymborg and Karen Lackey as the first members of its Therapeutic Innov...

Delivered in collaboration with the Manchester Cancer Research Centre and designed with working professionals in mind, this pioneering, patient-focussed course will give you the tools to lea...

A Newcastle-based life sciences company has raised £1.5m worth of investment to help develop a ground-breaking treatment that could provide a treatment for patients suffering from early sta...

Over 40,000 people of all ages, from children to adults, are diagnosed with blood cancers and related disorders every year in the UK. It is a complex disease area made up of over 100 individ...

The latest partnership between Paxman and the University of Huddersfield developing cooling wraps for use during chemotherapy earns UKRI's highest grade

Delivered in collaboration with the Manchester Cancer Research Centre and designed with working professionals in mind, this pioneering, patient-focussed course will give you the tools to lea...

“It has been a great privilege to be part of a project which empowers women to prioritise their health"

Following the success of 2022’s event, the Oncology & Precision Medicine Conference once again took place over two days to facilitate a more in-depth programme, with 149 delegates meeting...

World-leading research into diseases such as prostate cancer and mitochondrial disease at Northumbria University.

For the first time in 2022, the Oncology & Precision Medicine Conferences were a two-day event with 120 delegates coming together to discuss the current oncology landscape and the future of ...

An academic from Teesside University has been awarded £100,000 to fund essential brain cancer research, which aims to advance diagnosis and treatments.

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners